Skip to main content
Screener/Healthcare/Biotechnology

AXSM — Axsome Therapeutics, Inc.

NASDAQ
$132.45+2.65 (+2.04%)
Mid CapHealthcareFastest GrowingLow Beta
$123.00
$260.19
$130.00
$133.78
EPS (TTM)$-3.73
P/E Ratio-51.14
Dividend Yield—
Market Cap$7.57B
Volume372K
Prev Close$129.80
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$191.2M-$64.5M$-1.2692.3%-33.8%
Q4 '25$196.0M-$28.6M$-0.5693.7%-14.6%
Q3 '25$171.0M-$47.2M$-0.9493.0%-27.6%
Q2 '25$150.0M-$48.0M$-0.9791.0%-32.0%
Q1 '25$121.5M-$59.4M$-1.2291.9%-48.9%
Q4 '24$118.8M-$74.9M$-1.5491.1%-63.1%
Q3 '24$104.8M-$64.6M$-1.3491.9%-61.7%
Q2 '24$87.2M-$79.3M$-1.6790.8%-91.0%
Get Your Daily Market Recap